What Cigna Group (CI) Said on Its Q3 Earnings Call

Cigna Group (CI) reported Q3 2026 adjusted revenue of $73.8B and adjusted earnings of $2.1B, raising its full-year EPS outlook to at least $30.60. Cigna Healthcare saw 9% revenue growth, while Evernorth's revenue rose 6%. The company expects 10% EPS growth in 2027, with cost savings targeting $3B by 2030.

Original reporting
Published Nov 7, 2026, 7:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 12:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Cigna Group (CI) Said on Its Q3 Earnings Call — source image
Decision brief

The 30-second read

$CIBullishHigh
01

Why it matters

The guidance lift is a fresh, material disclosure that can drive the stock higher, especially ahead of market open.

02

Market read

First‑time earnings guidance raise for a large U.S. health insurer; likely bullish impact on CI and related healthcare stocks.

03

What to watch

Potential headwinds from ACA exchange exit and pharmacy benefit margin compression could limit upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Cigna Group reported Q3 2026 results, highlighted revenue growth, and announced higher full‑year earnings guidance for both its core insurance and Evernorth businesses.

Company-level read

Ticker impact

$CIBullishHigh confidence
Context

Cigna Group raised its full-year adjusted earnings outlook to at least $30.60 per share and increased its Evernorth earnings guidance, providing fresh guidance numbers not previously disclosed.

Expected impact

likely upward pressure as the market prices in higher earnings expectations

Evidence & confidence

The new earnings per share target and higher Evernorth outlook are material, first‑time disclosed figures that can move the share price.

Market effects

Positive for health insurance and PBM sector, may lift peers like UnitedHealth (UNH) and Anthem (ELV).

U.S. market may see modest gains in healthcare stocks.

Limited to U.S. healthcare sector; no broad macro impact.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pullback.

Key entities

  • Cigna Group

    U.S. health services insurer and PBM operator.

Related articles

$UNHMed

UnitedHealth and other insurance stocks drag down the Dow after CMS proposes new anti-fraud rule

UnitedHealth (UNH), Humana (HUM), Cigna (CI), and CVS Health (CVS) stocks fell 8%, 8%, 2%, and 3% respectively, dragging down the Dow after CMS proposed a new anti-fraud rule. The rule, called CRUSH, aims to increase audits and recover improper payments, potentially saving $90B over 10 years. Oppenheimer analysts expect legal challenges and note savings may not be broad.

$UNHHighAI 8/10

Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.